IRIS
TESTA, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.214
AS - Asia 2.627
NA - Nord America 1.549
SA - Sud America 650
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.097
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.091
US - Stati Uniti d'America 1.443
SG - Singapore 1.039
CN - Cina 717
IT - Italia 567
BR - Brasile 551
HK - Hong Kong 409
VN - Vietnam 236
FR - Francia 157
DE - Germania 90
GB - Regno Unito 65
SE - Svezia 56
AT - Austria 48
CA - Canada 48
IN - India 47
MX - Messico 45
BD - Bangladesh 35
NL - Olanda 35
FI - Finlandia 32
AR - Argentina 28
IQ - Iraq 23
ZA - Sudafrica 22
JP - Giappone 20
PL - Polonia 20
EC - Ecuador 19
ES - Italia 18
TR - Turchia 18
ID - Indonesia 16
VE - Venezuela 11
CL - Cile 10
CO - Colombia 9
PY - Paraguay 9
LT - Lituania 8
PE - Perù 8
UA - Ucraina 8
UZ - Uzbekistan 8
DZ - Algeria 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
SA - Arabia Saudita 6
NP - Nepal 5
AZ - Azerbaigian 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
PK - Pakistan 4
BE - Belgio 3
CH - Svizzera 3
HN - Honduras 3
IE - Irlanda 3
KE - Kenya 3
OM - Oman 3
PH - Filippine 3
UY - Uruguay 3
AM - Armenia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
ZM - Zambia 2
A1 - Anonimo 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 8.097
Salva come PNG Salva come JPEG
Città #
Singapore 509
Moscow 448
Hong Kong 405
Dallas 377
Ashburn 287
Hefei 169
San Jose 165
Milan 164
Lauterbourg 143
Shanghai 126
Beijing 106
Ho Chi Minh City 70
Hanoi 59
Los Angeles 50
Rome 48
Nuremberg 42
São Paulo 41
New York 39
Naples 30
Turin 28
Orem 26
Boardman 24
Brooklyn 23
Mexico City 22
Denver 21
Santa Clara 21
Bologna 19
Phoenix 19
Vienna 18
Warsaw 18
Amsterdam 17
Belo Horizonte 17
Lawrence 16
Princeton 16
Da Nang 15
Helsinki 15
London 15
Munich 15
Assago 14
Manchester 14
Johannesburg 13
Montreal 13
Tokyo 13
Toronto 13
Catania 12
Chennai 12
Frankfurt am Main 12
Bari 11
Chicago 11
Genoa 11
Poplar 11
Rio de Janeiro 11
Turku 11
Brasília 10
Brescia 10
Seattle 10
Quito 9
Stockholm 9
Atlanta 8
Boston 8
Dhaka 8
Figino 8
Porto Alegre 8
Salvador 8
Tashkent 8
Betim 7
Guangzhou 7
Houston 7
Manaus 7
Mumbai 7
Ribeirão Preto 7
Curitiba 6
Erbil 6
Falkenstein 6
Fortaleza 6
Goiânia 6
Guayaquil 6
Istanbul 6
Miami 6
New Delhi 6
Ninh Bình 6
San Francisco 6
Verona 6
Baghdad 5
Bergamo 5
Biên Hòa 5
Contagem 5
Council Bluffs 5
Florence 5
Haiphong 5
Monza 5
Padua 5
Perugia 5
Santiago 5
São Gonçalo 5
Thái Bình 5
Tianjin 5
Amman 4
Ankara 4
Baku 4
Totale 4.125
Salva come PNG Salva come JPEG
Nome #
Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women with Preconception Immunity (CHILd Study) 224
Coronary Protection to Prevent Coronary Obstruction During TAVR 113
Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis 95
Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study 87
Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis 85
Bailout From Sinus Jailing: In-Series TAVR-in-TAVR to Avoid Coronary Flow Obstruction 82
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 81
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 81
Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation. 80
Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves 77
Acute worsening in migraine symptoms following PFO closure: a matter of fact? 75
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis 73
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes 72
[SICI-GISE Position paper on the use of the magnesium bioresorbable scaffold Magmaris in clinical practice] 71
Extra- Mitral Valve Cardiac Involvement in Patients With Primary Mitral Regurgitation Undergoing Transcatheter Edgeto- Edge Repair 71
A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique 71
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 70
Impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair 69
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after TAVR: insights from the Recovery TAVR registry 69
Acute Kidney Injury after Transcatheter Aortic Valve Implantation with Self-expanding CoreValve Prosthesis: Results From a Large Multicenter Italian Research Project 69
Prognostic Significance of Flail Mitral Leaflet in Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation 69
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) (October, qcac063, 2022) 68
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death 67
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 67
Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation 67
Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves 66
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System 66
Assessing the Risk of Leaflet Motion Abnormality Following Transcatheter Aortic Valve Implantatio 66
Cardiac magnetic resonance for ischaemia and viability detection. Guiding patient selection to revascularization in coronary chronic total occlusions: The CARISMA_CTO study design 63
Cerebral Protection During Transcatheter Aortic Valve Implantation: An Updated Systematic Review and Meta-Analysis 62
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 62
Comparison of Incidence and Predictors of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Using the CoreValve Versus the Edwards Valve 62
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 62
Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR 61
TAVR-Associated Prosthetic Valve Infective Endocarditis : Results of a Large, Multicenter Registry. 60
Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR in Sievers Type 1 Bicuspid Aortic Valves 59
Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry 59
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 58
Real world safety and efficacy of transcatheter mitral valve repair with MitraClip. Thirty-day results from the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO) 58
Meta-Analysis of the Impact of Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Implantation 56
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 56
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 56
Letter by Testa et al regarding article, "presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention" 55
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves 54
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart) 54
The new era of oral anticoagulation: the 'finger pointing to the moon is not the moon'. Reply to: Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next? By Job Harenberg, Gregory Y.H. Lip 54
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis 54
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 54
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 54
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 53
Transcatheter valve-in-valve implantation using Corevalve Revalving System for failed surgical aortic bioprostheses 53
Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry 53
Myocardial perfusion imaging after coronary artery bypass surgery using cardiovascular magnetic resonance: a validation study 53
Current concepts on antiplatelet therapy: focus on the novel thienopyridine and non-thienopyridine agents 52
How should I treat a coronary "traffic jam"? A triple kissing balloon in distal left main trifurcation 52
One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system 52
Transcatheter Aortic Valve Implantation in Failed Bioprosthetic Surgical Valves 51
Emerging Technologies for Percutaneous Mitral Valve Repair 51
Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves 51
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 50
Transcatheter Aortic Valve-in-Valve Implantation Using Lotus Valve for Failed Surgical Bioprostheses 50
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition 50
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 50
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 50
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 50
Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis 49
SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice 49
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 49
XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial 49
Role of imaging in interventions on structural heart disease 49
RENASCENT III First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results 48
Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery 48
Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis 48
What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel 48
Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting 48
Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis 48
Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis 48
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study 47
The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention 47
Pexelizumab and survival in cardiac surgery 47
Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients With Failing Bioprosthetic Aortic Valves: Mid-term Outcomes From the Italian CoreValve Clinical Service Project 47
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 47
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement 47
Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging 46
Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Midterm Evaluation of Valve-in-Valve and Valve-in-Ring Implantation From the VIVID Registry 46
Infective Endocarditis Following Transcatheter Aortic Valve Replacement: Comparison of Balloon- Versus Self-Expandable Valves 45
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 45
Epidemiology of stroke and cerebral protection in patients undergoing transcatheter aortic valve replacement 45
Early Diagnosis of Perioperative Myocardial Infarction After Coronary Bypass Grafting: A Study Using Biomarkers and Cardiac Magnetic Resonance Imaging. 44
Primum non nocere”: case report of patient with aortic valve replacement and subsequent occlusion of an anomalous circumflex artery 44
Transcatheter mitral valve regurgitation treatment: State of the art and a glimpse to the future 44
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 43
Response to Letter by Prinzen et al Regarding Article "Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System" 43
Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation 42
Persistence of Severe Pulmonary Hypertension After Transcatheter Aortic Valve Replacement: Incidence and Prognostic Impact 42
Selection of Medications to Prevent Stroke Among Individuals With Atrial Fibrillation : Update on Prevention of Stroke in Patients with AF 42
With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention 42
Transcatheter Treatment of Tricuspid and Mitral Regurgitation: Similar Path, Different Stages 42
Outcome of transcatheter aortic valve replacement in bicuspid aortic valve stenosis with new-generation devices 42
Targeting "diabetic" coronary stenosis merging the properties of sirolimus coated balloon with sirolimus eluting stent 41
Totale 5.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 1 0 0 2 0 4 9 0 3 1 0 4
2022/2023122 38 21 11 3 8 15 3 5 2 0 2 14
2023/202470 18 3 6 3 0 6 0 5 3 2 5 19
2024/20251.730 53 20 5 158 60 167 359 183 221 221 145 138
2025/20266.401 561 425 460 787 483 564 560 392 1.957 212 0 0
Totale 8.356